NCT04894643 2026-03-20
PARC
EBG MedAustron GmbH
Phase NA Recruiting
Clinical Trials
11 trialsNCT07139587 2025-09-10
The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Hebei General Hospital
Phase NA Not yet recruiting
NCT05653817 2022-12-16
Advanced or Metastatic Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT04675866 2022-04-15
Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
Henan Cancer Hospital
Phase NA Unknown
NCT05287308 2022-03-31
Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
ChineseAMS
Phase NA Not yet recruiting
NCT04443036 2020-06-23
Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma
China Medical University, China
Phase NA Unknown
NCT03647514 2018-12-10
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT03647280 2018-12-07
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01698710 2017-06-21
Endoscopic Abraxane Injection Into Pancreatic Cysts
Massachusetts General Hospital
Phase NA Terminated
NCT01442974 2013-03-13
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
Grupo Hospital de Madrid
Phase NA Completed
NCT00308178 2013-02-18
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed